Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(10 sites)

United States

City of Hope Cancer Center (Data Collection Only), Duarte, California

Stanford University Medical Center, Stanford, California

University of Miami, Miami, Florida

Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey

Memorial Sloan Kettering Monmouth, Middletown, New Jersey

Memorial Sloan Kettering Bergen, Montvale, New Jersey

Memorial Sloan Kettering Cancer Center @ Commack, Commack, New York

Memorial Sloan Kettering Westchester, Harrison, New York

Memorial Sloan Kettering Cancer Center, New York, New York

Memorial Sloan Kettering Nassau, Uniondale, New York